Bringing New Cell Therapies to Market Requires Top-Notch Logistics and Operational ... (Rockville Maryland (PRWEB) January 24 20...)

Bringing New Cell Therapies to Market Requires Top-Notch Logistics and Operational Efficiency

Date:1/24/2013

Rockville, Maryland (PRWEB) January 24, 2013

(January 22nd, 2013) — Fisher BioServices, the world’s leading provider of biospecimen storage, cell therapy logistics and related clinical trial services, announced today that Mr. Dan O’Donnell, Associate Director of Cell Therapy Logistics at Fisher BioServices, and Mr. Bruce C. Simpson, Director of Commercial Operations at Fisher BioServices, will be presenting at the 2013 Phacilitate Cell & Gene Therapy Forum, January 28-30, in Washington, DC. This year’s Forum focuses on bringing therapeutics “From Promise to Products” and features presentations and roundtable discussions on positioning new cell and gene therapies for commercial success.

Companies with cell-based therapies nearing clinical trials and FDA approval face the challenge of transporting their product in compliance with FDA requirements for cold chain / chain of custody documentation. Mr. O’Donnell and Mr. Simpson are recognized industry experts on the handling and distribution of gene and cell-based therapies, and will be sharing the latest innovations on the distribution of cell-based products and regenerative medicines from the manufacturer to the patient, while complying with all applicable Title 21 CFR criteria.

The critical issues of commercial viability will be addressed in the first plenary session, and will include valuing cell therapies, reimbursement in the current healthcare environment, and other factors that may influence a product’s commercial success, including distribution systems.

During this session, Mr. O’Donnell will outline the variables that must be considered during every point of transfer in the delivery of cell therapies to the patient, and will discuss the challenges and technical considerations involved in moving cryogenically frozen products around the world.
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2 3
Related biology technology :

1. ORNL wins 9 R&D 100s, bringing total to 173
2. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
3. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
4. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
5. BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel
6. BioRestorative Therapies Obtains $2.1 Million in 2012 Private Financing
7. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
8. BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device
9. CNIO researchers describe a new target for developing anti-angiogenic and anti-tumoral therapies
10. BioRestorative Therapies Enters Into Brown Fat Research Agreement With University of Utah
11. CSL Biotherapies Awarded US Government Contract for Influenza Pandemic Preparedness and Response

Post Your Comments:

(Date:5/21/2013)... Bed bugs have become so widespread in the past ... to chemical-based pesticides for help to completely get rid of ... solutions present, the company advised the public to kill ... According to My Cleaning Products, chemical-based pesticides are not as ... shared that the pests have already developed immunity to the ...

(Date:5/21/2013)... Minneapolis, MN (PRWEB) May 21, 2013 ... a patented automatic colony counter, announced today that they ... four products , the IncuCount, IntelliCount, InCount and ... price and sophistication are especially useful in food microbiology ... been given an updated look. A bright white ...

(Date:5/21/2013)... NANONEX CORPORATION, a pioneer and leading company ... successful delivery and installation of a new nanoimprint ... major Japanese manufacturing company. , ... lithography tool that has the ability to process ... types. Based on Nanonex inventions and proprietary technologies, ...

(Date:5/21/2013)... Mississauga, Ontario (PRWEB) May 21, 2013 ... expert scientists of the ITN to design the ... usefulness of two key clinical models used in ... Chamber (EEC) and Nasal Allergen Challenge (NAC) models. ... supported by numerous publications, to date no direct ...

Breaking Biology Technology:New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2 New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3 Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2 Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2 Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2

[0] New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests [0] Revolutionary Science Announces New Automatic and Manual Colony Counting Products [0] Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing [0] Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation.

... FRANCISCO, Feb. 14 BioSpace, the world,s ... announced today the,expansion of its reach to ... by its parent company, onTargetjobs. With the,inclusion ... Internet job boards, BioSpace now offers biotechnology,pharmaceutical, ...

... Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP), ... today announced unaudited interim and annual,consolidated financial ... ended,December 31, 2007. The unaudited financial results ... as described under the section "Financial,Information"., ...

... Provides Full Year 2008 Revenue Guidance of $350 million ... Symmetry Medical Inc.,(NYSE: SMA ), an independent provider ... medical markets, today reported preliminary,fourth quarter 2007 revenue of ... not be reported at this time., As previously ...

BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition Angiotech announces results for the fourth quarter ended December 31, 2007 Symmetry Medical Reports Preliminary Fourth Quarter Revenue

(Date:5/20/2013)... also commonly resistant to antimicrobial substances made by ... mBio , the online open-access journal of ... and host antimicrobials LL-37 and lysozyme, which help ... that patients with life-threatening multi-drug resistant infections are ... is a last-line drug for treating several kinds ...

(Date:5/20/2013)... PAUL (MAY 20, 2013) University of Minnesota Medical ... Minnesota, in partnership with the University,s Brain Tumor Program, ... nerve sheath tumors (MPNST) that allow them to discover ... cancer. , The research was published this week in ... Sleeping Beauty transposon method, researchers in the lab of ...

(Date:5/20/2013)... about the effect of physical education (PE) on child ... that increasing the amount of time that elementary schoolchildren ... , The study represents some of the first evidence ... and is forthcoming in the Journal of Health ... study can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , ...

Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2 Resistance to last-line antibiotic makes bacteria resistant to immune system 3 U of M researchers develop model for better testing, targeting of MPNST 2 Gym class reduces probability of obesity, study finds for first time 2

[0] Resistance to last-line antibiotic makes bacteria resistant to immune system [0] U of M researchers develop model for better testing, targeting of MPNST [0] Gym class reduces probability of obesity, study finds for first time

... ANN ARBOR, Mich.---An international team co-led by scientists from ... the genome with DNA variants that are associated with increased ... A variant is a place on a string of ... people. At most places along the DNA, any two people ...

... , VILLINGEN-SCHWENNINGEN, Germany , June 30 Multicard ... INV) and an identity management systems integrator and solutions provider, announced ... Secure IT kits has been selected under the new electronic identification ... ("Bundesministerium des Innern"). , , ...

... dramatic new real-world evidence supporting the idea that hand ... appears in a new study showing a connection between ... drinking water, and health in households in a developing ... Environmental Science & Technology , a semi-monthly journal. ...

Cached Biology News:New variants found that indicate a predisposition to type 2 diabetes 2 Multicard to Supply Secure IT Kits Under German Federal Government's Electronic ID Program 2 Multicard to Supply Secure IT Kits Under German Federal Government's Electronic ID Program 3

New variants found that indicate a predisposition to type 2 diabetes Multicard to Supply Secure IT Kits Under German Federal Government's Electronic ID Program Real-world proof of hand washing's effectiveness

PEG 8000 is used in the precipitation of phage, isolation of plasmid DNA and the enhancement of blunt-ended ligation reactions....

Recombinant Mouse Matrilin-4, CF Protein Family: Extracellular Matrix Molecules, Chondrogenesis Markers...

... all types of yeast two-hybrid studies, including complex interaction ... Choice of two bait vectors for maximum flexibility ... Triple reporter strain NMY51 ensures ... Complete set of controls: pLexA-p53, pLexA-lamin C ...

PlusOne EDTA, disodium salt, 100 g. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Buffers....

Biology Products:

PEG 8000 Powder from Promega Mouse Matrilin-4 from R&D Systems DUALhybrid kit from Dualsystems Biotech AG PlusOne EDTA, disodium salt from GE Healthcare, formerly Amersham Biosciences